Back
Can Fite Biofarma Vs. BioLine Rx Industry Stock Comparison
Buy
59
CANF
Can Fite Biofarma
Last Price:
3.45
Seasonality Move:
-6.47%
Sell
49
BLRX
BioLine Rx
Last Price:
0.67
Seasonality Move:
3%
Buy
59
Can Fite Biofarma (CANF)
is a Buy
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $3.35. The Score for CANF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- CANF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
BioLine Rx (BLRX)
is a Sell
Is BioLine Rx a Buy, Sell or Hold?
- The current BioLine Rx [BLRX] share price is $0.67. The Score for BLRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- BLRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $3.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CANF is experiencing selling pressure, which indicates risk of future bearish movement.
BLRX Stock Price Chart
What is BioLine Rx's stock price today?
-
The BioLine Rx share price today is $0.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight buying pressure.
CANF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.26 | Buy |
Relative Strength Index (14 RSI): | 70.81 | Buy |
Chaikin Money Flow: | -431492 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.14 - 2.88) | Buy |
Bollinger Bands (100): | (1.94 - 2.48) | Buy |
BLRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 47.29 | Sell |
Chaikin Money Flow: | 38631 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.62 - 0.72) | Sell |
Bollinger Bands (100): | (0.66 - 1.18) | Sell |
CANF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.88 | Buy |
20-day SMA: | 2.61 | Buy |
50-day SMA: | 2.3 | Buy |
200-day SMA: | 2.23 | Buy |
8-day EMA: | 3 | Buy |
20-day EMA: | 2.68 | Buy |
50-day EMA: | 2.42 | Buy |
200-day EMA: | 2.49 | Buy |
BLRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.68 | Sell |
20-day SMA: | 0.68 | Sell |
50-day SMA: | 0.67 | Sell |
200-day SMA: | 1.27 | Sell |
8-day EMA: | 0.68 | Sell |
20-day EMA: | 0.68 | Sell |
50-day EMA: | 0.74 | Sell |
200-day EMA: | 1.08 | Sell |
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.
BioLine Rx Earnings Growth & BLRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.10 per share.
Can Fite Biofarma Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BioLine Rx Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |